Citigroup Inc Vbi Vaccines Inc Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.38 - $22.5 $2,614 - $154,777	-6,879 Reduced 84.12%	1,299 $0
Q3 2022 Nov 10, 2022	SELL	$0.73 - $23.4 $7,583 - $243,102	-10,389 Reduced 55.95%	8,178 $6,000
Q2 2022 Aug 10, 2022	SELL	$0.66 - $1.81 $104,158 - $285,646	-157,816 Reduced 89.47%	18,567 $15,000
Q1 2022 May 12, 2022	SELL	$1.27 - $2.47 $603,801 - $1.17 Million	-475,434 Reduced 72.94%	176,383 $293,000
Q4 2021 Feb 10, 2022	BUY	$2.21 - $3.22 $743,450 - $1.08 Million	336,403 Added 106.65%	651,817 $1.53 Million
Q3 2021 Nov 10, 2021	BUY	$2.8 - $3.72 $883,159 - $1.17 Million	315,414 New	315,414 $981,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.